Designs and develops percutaneous transcatheter devices for the treatment of mitral valve regurgitation (a significant factor in congestive heart failure.)
Total raised: $88M
Investors 3
| Date | Name | Website |
| - | Forbion | forbion.co... |
| - | Qiming Ven... | qimingvent... |
| - | Qiming Ven... | qimingvc.c... |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 17.05.2016 | Series E | $40M | - |
| 20.06.2014 | - | $8M | - |
| 16.05.2012 | Series D | $35M | - |
| 19.07.2010 | - | $5M | - |
Mentions in press and media 12
| Date | Title | Description |
| 17.05.2016 | Mitralign Raises $39.8M in Series E Equity Funding | Mitralign, Inc., a near Boston, Massachusetts, USA-based valve repair company, raised $39.8m in Series E equity funding. The backers were not disclosed. Led by Rick Geoffrion, chief executive officer, Mitralign develops direct transcatheter... |
| 17.05.2016 | Mitralign Grabs $40M Series E Funding | TEWKSBURY, MA, Mitralign, an innovative developer of direct transcatheter mitral and tricuspid valve repair solutions, announced today it has raised $39.8 million to date in a Series E equity round of financing. >> Click here for m... |
| 20.06.2014 | Mitralign raises another $8M | Mitralign added more than $8 million to its coffers in an equity funding round, after closing enrollment of a clinical trial for its namesake mitral valve repair device in April. The Mitralign system is designed to deliver via catheter at l... |
| 25.07.2012 | Fundraising: Percutaneous mitral valve repair company raises $14.8 million | Industry: Medical Devices Products: Developing PerCu-Pro System that is an implanted device to percutaneously repair the mitral valve to prevent blood leaking into the left ventricle (also known as mitral valve regurgitation); the Dexterity... |
| 16.05.2012 | Mitralign Raises $35 Million Series D Financing | - |
| 16.05.2012 | Mitralign Closes $35M in Series D Financing | Mitralign Inc., a Tewksbury, Mass.-based cardiac device company, has closed $35m in Series D financing. The round was led by Forbion Capital Partners, with participation from Saints Venture Capital, Oxford Bioscience Partners, Triathlon Med... |
| 16.05.2012 | Mitralign Raises $35M Series D Financing | TEWKSBURY, MA, Cardiac device company leading the way in percutaneous mitral valve repair, today announced the closing of a $35 million Series D round of funding. >> Click here for more funding data on Mitralign >> To export... |
| 01.09.2010 | Feds indict former Spectranetics execs | A federal grand jury indicted Spectranetics Corp.’s (NSDQ:SPNC) former CEO, two other former executives and a consultant on charges stemming from their alleged illegal importation of laser medical devices for a clinical trial. John Schulte,... |
| 19.07.2010 | Mitralign Receives $5m Senior Secured Credit Facility from GE Capital | Mitralign, Inc., a Tewksbury, Massachusetts-based company developing an innovative, catheter-based method to effectively treat mitral regurgitation in patients suffering from congestive heart failure, has received a $5m senior secured credi... |
| 19.07.2010 | Mitralign wins $5 million credit line from GE Capital | GE Capital’s Healthcare Financial Services division gave Mitralign Inc. a $5 million line of credit. Mitralign is developing a catheter-based mitral valve repair device. The Tewksbury, Mass.-based firm plans to use the loan as working capit... |
Show more